Darren Jensen
Analyst · Lane Research. Please proceed with your question
Thank you, Scott and good afternoon everyone. I hope you are all doing well and are staying safe and healthy during this unprecedented time. During fiscal 2020, we faced ever changing challenges resulting from the COVID-19 global pandemic, but we are very pleased with how we have remained nimble and have adapted quickly finishing the year with record full year revenue. We generated healthy growth for both the fourth quarter and the full fiscal year growing revenue and EBITDA of 5.7% and 6.7% respectively on a year-over-year basis and 3.1% and 31.3% respectively for the full fiscal year. We ended fiscal 2020 with robust growth in the number of active independent distributors in both the Americas and Asia-Pacific and Europe regions, and new enrollments have consistently improved throughout the calendar year. The increase in distributors is a testament to the strength of our entrepreneurial business model, our proprietary product offering and the investments we have been making in technology and digital tools. More people are turning to alternative ways to make or supplement their income during this time of financial uncertainty and our business model is ideally suited for this environment. Our focus on nutrigenomics is also resonating in a time when consumers around the world are increasingly focused on their health. Our distributors are leading with these messages through their social media and leveraging technology and digital tools, which is driving rising consumer interest. I am very pleased with our entire organization’s ability to quickly adapt to the environment presented by the COVID-19 pandemic. While the effects of the pandemic initially dragged our results during the third quarter and early in the fourth quarter, growth recovered as the quarter progressed and we finished strong. Our employees continue to work effectively in a work-from-home model. Our distributors are successfully utilizing technology and social media to grow their businesses. Our supply chain remains secure and our third-party suppliers are ensuring a steady supply of products. During the fourth quarter, we proactively invested in promotions and incentives to drive distributor growth in part by redirecting some of our expense savings from travel and local events, which had to be put on hold. Our utilization of a free start kit promotion, a $50 value for new distributors, was a driver during the month of April, supporting enhanced enrollment activities and growth. This promotion was then followed by our Flip the Switch program in May and June, which further accelerated our enrollments and revenue through the quarter. We were also successful with our Red Carpet program, which is focused on attracting experienced direct selling professionals to build with LifeVantage. In addition to supporting our supply chain and our valued customers and distributors, our focus quickly turned to the importance of the tools and the technology that connect them. Before the pandemic, we have recruited and created a new digital technology development team to continue the growth of our mobile app and advanced our digital infrastructure. As soon as the pandemic hit, that team started rethinking how we use this technology and their efforts, along with the efforts of our entire digital marketing team, have accelerated adoption and created new ways of thinking about our strategic technology roadmap that will be transformational for our business long after the current pandemic. Our business model, where 70% of our sales are on subscription, provides reoccurring revenue and limits volatility during times of external disruption as we have seen over the past several months. We saw continued revenue growth in both of our geographical regions during the fourth quarter and fiscal year, with particular strength in Taiwan, Australia, and New Zealand and continued growth in Japan despite the external challenges in this market to direct selling given social distancing requirements and the limitations on cyber recruiting. As we look forward toward fiscal 2021, while the current environment provides uncertainty, we are confident in our ability to adapt and drive the business forward. We are effectively operating virtually and remain focused on the key metrics that drive our business, including enrollments, attrition, average revenue per account, and net promoter score. We are anticipating further investments in our technology, tools and promotions that will build upon our digital foundation in support of these key metrics as we propel the company into the future. We plan to continue to drive our long-term growth through the expansion of our global footprint and further new product innovation. We anticipate new market entrances and new product launches during fiscal 2021. We expect to launch in Singapore and Malaysia this coming year and to make additional new market announcements as the year progresses. Finally, I want to thank each and every one of our LifeVantage team members for their continued focus and commitment to our company during these difficult times, delivering the products that our customers depend on. We are confident in our business model, the adaptability of our employees and the passion and commitment of our distributor base to continue to not only survive, but thrive during these uncertain times. With that, let me turn it over to Steve to run through the financial results. Steve?